Shai Libson
YOU?
Author Swipe
View article: Chemical Nose-Based Non-Invasive Detection of Breast Cancer Using Exhaled Breath
Chemical Nose-Based Non-Invasive Detection of Breast Cancer Using Exhaled Breath Open
Breast cancer (BC) is the most commonly occurring cancer in women and one of the leading causes of cancer death in women worldwide. BC mortality is related to early tumor detection, highlighting the importance of early detection methods. T…
View article: Stage I (T1N0M0) breast cancer with a median follow-up of 14 years: A retrospective cohort study of 328 consecutive patients and the prognostic value of tumor size, grade, and subtype
Stage I (T1N0M0) breast cancer with a median follow-up of 14 years: A retrospective cohort study of 328 consecutive patients and the prognostic value of tumor size, grade, and subtype Open
Purpose This study aimed to evaluate the long-term outcomes of stage I breast cancer(BC) patients diagnosed during the current era of screening mammography, immunohistochemistry receptor testing, and systemic adjuvant therapy. The primary …
View article: Neoadjuvant Therapy with Doxorubicin-Cyclophosphamide Followed by Weekly Paclitaxel in Early Breast Cancer: A Retrospective Analysis of 200 Consecutive Patients Treated in A Single Center with A Median Follow-Up of 9.5 Years.
Neoadjuvant Therapy with Doxorubicin-Cyclophosphamide Followed by Weekly Paclitaxel in Early Breast Cancer: A Retrospective Analysis of 200 Consecutive Patients Treated in A Single Center with A Median Follow-Up of 9.5 Years. Open
Purpose We analyzed outcomes of doxorubicin-cyclophosphamide(AC) followed by weekly paclitaxel as neoadjuvant chemotherapy(NAC) for breast cancer(BC), in an everyday practice with long-term follow-up of patients. Methods All patients (n=20…
View article: Post Mastectomy Radiation for Stage II Breast Cancer Patients with T1/T2 Lesions
Post Mastectomy Radiation for Stage II Breast Cancer Patients with T1/T2 Lesions Open
ER negative status, high grade and node negativity were associated with LRR. A prospective trial randomizing stage II BC patients with T1/T2 lesions, negative hormone receptors and high-grade tumors to PMR following mastectomy arm vs. no r…